Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Point72 Asset Management, L.P. reported a 6.90% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Point72 Asset Management, L.P. reported a 6.90% stake in Dianthus Therapeutics, Inc., 2,981,674 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
6.90%
Shares
2,981,674
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.6.90%2,981,674
Point72 Capital Advisors, Inc.6.90%2,981,674
Steven A. Cohen6.90%2,981,674

Source

View original at SEC

Related